QH-106

N/A

Report date: 2025/08/14 20:00:07

Base Information

Drug NameQH-106

Drug Alias NameCD7 CAR-γδT cell therapy (Anhui Provincial Hospital)QH106QH-106

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsT-cell antigen CD7 modulators

TargetsT-cell antigen CD7

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAnhui Provincial Hospital

China Registration ClassN/A

Develop Information

Active CompaniesAnhui Provincial Hospital

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A